Literature DB >> 6150666

Absorption of ipecac alkaloids in emergency patients.

D M Moran, D J Crouch, B S Finkle.   

Abstract

Syrup of ipecac contains the nauseant alkaloids emetine and cephaeline. Although thousands of doses are given yearly, no data exist on the absorption of these alkaloids in man. We gave 30 mL of USP Syrup to ten adult patients. Blood and urine samples were obtained at approximately one-half and two hours after administration, and the entire volume of vomitus was saved. The samples were then analyzed for cephaeline and emetine by a high-performance liquid chromatographic (HPLC) assay developed in our laboratory. All patients vomited within 30 minutes, but the amounts of alkaloid regurgitated varied from 22 +/- 14% in six patients to 80 +/- 16% in the remaining four. Only six patients had emetine or cephaeline in their blood by two hours (range, 5 to 73 ng/mL), although ten patients had detectable concentrations of the alkaloids in their urine. Measured over two hours, no patient eliminated more than 0.5% of the dose by the urinary route. In our study ipecac was absorbed by all who received it; the extent of absorption varied widely, and elimination by the renal route was small.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6150666     DOI: 10.1016/s0196-0644(84)80332-7

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  2 in total

1.  Drug abuse and the accident and emergency department.

Authors:  A D Redmond
Journal:  Arch Emerg Med       Date:  1985-06

2.  Absorption, distribution and excretion of 3H-labeled cephaeline- and emetine-spiked ipecac syrup in rats.

Authors:  Takayuki Asano; Kazuhisa Ishihara; Yoko Wakui; Toshihiko Yanagisawa; Masayuki Kimura; Hideo Kamei; Takemi Yoshida; Yukio Kuroiwa; Yuichi Fujii; Mamoru Yamashita; Takanori Kuramochi; Hiroki Tomisawa; Mitsuru Tateishi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2002 Jan-Mar       Impact factor: 2.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.